JP2019522459A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019522459A5 JP2019522459A5 JP2018554100A JP2018554100A JP2019522459A5 JP 2019522459 A5 JP2019522459 A5 JP 2019522459A5 JP 2018554100 A JP2018554100 A JP 2018554100A JP 2018554100 A JP2018554100 A JP 2018554100A JP 2019522459 A5 JP2019522459 A5 JP 2019522459A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- cdr
- polypeptide chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 641
- 229920001184 polypeptide Polymers 0.000 claims 121
- 102000004196 processed proteins & peptides Human genes 0.000 claims 121
- 108090000765 processed proteins & peptides Proteins 0.000 claims 121
- 102000014914 Carrier Proteins Human genes 0.000 claims 65
- 108091008324 binding proteins Proteins 0.000 claims 65
- 239000000427 antigen Substances 0.000 claims 40
- 102000036639 antigens Human genes 0.000 claims 40
- 108091007433 antigens Proteins 0.000 claims 40
- -1 CCL17 Proteins 0.000 claims 38
- 238000006467 substitution reaction Methods 0.000 claims 29
- 102000004169 proteins and genes Human genes 0.000 claims 26
- 108090000623 proteins and genes Proteins 0.000 claims 26
- 102100027207 CD27 antigen Human genes 0.000 claims 15
- 101000914511 Homo sapiens CD27 antigen Proteins 0.000 claims 15
- 102100029722 Ectonucleoside triphosphate diphosphohydrolase 1 Human genes 0.000 claims 13
- 150000001413 amino acids Chemical class 0.000 claims 13
- 101001012447 Homo sapiens Ectonucleoside triphosphate diphosphohydrolase 1 Proteins 0.000 claims 12
- 239000008194 pharmaceutical composition Substances 0.000 claims 12
- 101000666896 Homo sapiens V-type immunoglobulin domain-containing suppressor of T-cell activation Proteins 0.000 claims 11
- 108700012920 TNF Proteins 0.000 claims 11
- 102100038282 V-type immunoglobulin domain-containing suppressor of T-cell activation Human genes 0.000 claims 11
- 101001019455 Homo sapiens ICOS ligand Proteins 0.000 claims 9
- 101001002634 Homo sapiens Interleukin-1 alpha Proteins 0.000 claims 9
- 102100034980 ICOS ligand Human genes 0.000 claims 9
- 102100020881 Interleukin-1 alpha Human genes 0.000 claims 9
- 206010028980 Neoplasm Diseases 0.000 claims 9
- 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 claims 8
- 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 claims 8
- 238000000034 method Methods 0.000 claims 8
- 101100286681 Homo sapiens IL13 gene Proteins 0.000 claims 7
- 101001002709 Homo sapiens Interleukin-4 Proteins 0.000 claims 7
- 102000055229 human IL4 Human genes 0.000 claims 7
- 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 claims 6
- 102100029822 B- and T-lymphocyte attenuator Human genes 0.000 claims 6
- 102100036846 C-C motif chemokine 21 Human genes 0.000 claims 6
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims 6
- 102100035943 HERV-H LTR-associating protein 2 Human genes 0.000 claims 6
- 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 claims 6
- 101000864344 Homo sapiens B- and T-lymphocyte attenuator Proteins 0.000 claims 6
- 101000713085 Homo sapiens C-C motif chemokine 21 Proteins 0.000 claims 6
- 101001021491 Homo sapiens HERV-H LTR-associating protein 2 Proteins 0.000 claims 6
- 101001117317 Homo sapiens Programmed cell death 1 ligand 1 Proteins 0.000 claims 6
- 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 claims 6
- 102100029527 Natural cytotoxicity triggering receptor 3 ligand 1 Human genes 0.000 claims 6
- 102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 claims 6
- 102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 claims 6
- 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 claims 6
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims 5
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims 5
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims 5
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims 5
- 108010009254 Lysosomal-Associated Membrane Protein 1 Proteins 0.000 claims 5
- 102100035133 Lysosome-associated membrane glycoprotein 1 Human genes 0.000 claims 5
- 210000001744 T-lymphocyte Anatomy 0.000 claims 5
- 210000004027 cell Anatomy 0.000 claims 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 4
- 108010047041 Complementarity Determining Regions Proteins 0.000 claims 4
- 101150029707 ERBB2 gene Proteins 0.000 claims 4
- 108060003951 Immunoglobulin Proteins 0.000 claims 4
- 102000013463 Immunoglobulin Light Chains Human genes 0.000 claims 4
- 108010065825 Immunoglobulin Light Chains Proteins 0.000 claims 4
- 108090000176 Interleukin-13 Proteins 0.000 claims 4
- 102000003816 Interleukin-13 Human genes 0.000 claims 4
- 102000004388 Interleukin-4 Human genes 0.000 claims 4
- 108090000978 Interleukin-4 Proteins 0.000 claims 4
- 102000004890 Interleukin-8 Human genes 0.000 claims 4
- 108090001007 Interleukin-8 Proteins 0.000 claims 4
- 102000000585 Interleukin-9 Human genes 0.000 claims 4
- 108010002335 Interleukin-9 Proteins 0.000 claims 4
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 4
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 4
- 102000018358 immunoglobulin Human genes 0.000 claims 4
- BGFTWECWAICPDG-UHFFFAOYSA-N 2-[bis(4-chlorophenyl)methyl]-4-n-[3-[bis(4-chlorophenyl)methyl]-4-(dimethylamino)phenyl]-1-n,1-n-dimethylbenzene-1,4-diamine Chemical compound C1=C(C(C=2C=CC(Cl)=CC=2)C=2C=CC(Cl)=CC=2)C(N(C)C)=CC=C1NC(C=1)=CC=C(N(C)C)C=1C(C=1C=CC(Cl)=CC=1)C1=CC=C(Cl)C=C1 BGFTWECWAICPDG-UHFFFAOYSA-N 0.000 claims 3
- 101100339431 Arabidopsis thaliana HMGB2 gene Proteins 0.000 claims 3
- 208000032679 Autosomal recessive spastic paraplegia type 64 Diseases 0.000 claims 3
- 108010008014 B-Cell Maturation Antigen Proteins 0.000 claims 3
- 102000006942 B-Cell Maturation Antigen Human genes 0.000 claims 3
- 101000840545 Bacillus thuringiensis L-isoleucine-4-hydroxylase Proteins 0.000 claims 3
- 102100024167 C-C chemokine receptor type 3 Human genes 0.000 claims 3
- 101710149862 C-C chemokine receptor type 3 Proteins 0.000 claims 3
- 101710149863 C-C chemokine receptor type 4 Proteins 0.000 claims 3
- 102100023703 C-C motif chemokine 15 Human genes 0.000 claims 3
- 102100036842 C-C motif chemokine 19 Human genes 0.000 claims 3
- 102100036848 C-C motif chemokine 20 Human genes 0.000 claims 3
- 102100036849 C-C motif chemokine 24 Human genes 0.000 claims 3
- 102100021933 C-C motif chemokine 25 Human genes 0.000 claims 3
- 102100021935 C-C motif chemokine 26 Human genes 0.000 claims 3
- 102100032367 C-C motif chemokine 5 Human genes 0.000 claims 3
- 102100032366 C-C motif chemokine 7 Human genes 0.000 claims 3
- 102100034871 C-C motif chemokine 8 Human genes 0.000 claims 3
- 102100028990 C-X-C chemokine receptor type 3 Human genes 0.000 claims 3
- 102100025277 C-X-C motif chemokine 13 Human genes 0.000 claims 3
- 102100039521 C-type lectin domain family 9 member A Human genes 0.000 claims 3
- 102100032976 CCR4-NOT transcription complex subunit 6 Human genes 0.000 claims 3
- 102100024263 CD160 antigen Human genes 0.000 claims 3
- 102100038078 CD276 antigen Human genes 0.000 claims 3
- 101150013553 CD40 gene Proteins 0.000 claims 3
- 102100032937 CD40 ligand Human genes 0.000 claims 3
- 102100025221 CD70 antigen Human genes 0.000 claims 3
- 101100328097 Caenorhabditis elegans clec-91 gene Proteins 0.000 claims 3
- 108091007854 Cdh1/Fizzy-related Proteins 0.000 claims 3
- 102100035294 Chemokine XC receptor 1 Human genes 0.000 claims 3
- 102000012286 Chitinases Human genes 0.000 claims 3
- 108010022172 Chitinases Proteins 0.000 claims 3
- 102100038497 Cytokine receptor-like factor 2 Human genes 0.000 claims 3
- 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 claims 3
- 102100023688 Eotaxin Human genes 0.000 claims 3
- 102100040859 Fizzy-related protein homolog Human genes 0.000 claims 3
- 102100020997 Fractalkine Human genes 0.000 claims 3
- 108090000369 Glutamate Carboxypeptidase II Proteins 0.000 claims 3
- 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 claims 3
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 claims 3
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims 3
- 108700010013 HMGB1 Proteins 0.000 claims 3
- 101150021904 HMGB1 gene Proteins 0.000 claims 3
- 102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 claims 3
- 102100038006 High affinity immunoglobulin epsilon receptor subunit alpha Human genes 0.000 claims 3
- 102100037907 High mobility group protein B1 Human genes 0.000 claims 3
- 101000978376 Homo sapiens C-C motif chemokine 15 Proteins 0.000 claims 3
- 101000713106 Homo sapiens C-C motif chemokine 19 Proteins 0.000 claims 3
- 101000713099 Homo sapiens C-C motif chemokine 20 Proteins 0.000 claims 3
- 101000713078 Homo sapiens C-C motif chemokine 24 Proteins 0.000 claims 3
- 101000897486 Homo sapiens C-C motif chemokine 25 Proteins 0.000 claims 3
- 101000897493 Homo sapiens C-C motif chemokine 26 Proteins 0.000 claims 3
- 101000797762 Homo sapiens C-C motif chemokine 5 Proteins 0.000 claims 3
- 101000797758 Homo sapiens C-C motif chemokine 7 Proteins 0.000 claims 3
- 101000946794 Homo sapiens C-C motif chemokine 8 Proteins 0.000 claims 3
- 101000916050 Homo sapiens C-X-C chemokine receptor type 3 Proteins 0.000 claims 3
- 101000858064 Homo sapiens C-X-C motif chemokine 13 Proteins 0.000 claims 3
- 101000888548 Homo sapiens C-type lectin domain family 9 member A Proteins 0.000 claims 3
- 101000884279 Homo sapiens CD276 antigen Proteins 0.000 claims 3
- 101000934356 Homo sapiens CD70 antigen Proteins 0.000 claims 3
- 101000804783 Homo sapiens Chemokine XC receptor 1 Proteins 0.000 claims 3
- 101000956427 Homo sapiens Cytokine receptor-like factor 2 Proteins 0.000 claims 3
- 101000978392 Homo sapiens Eotaxin Proteins 0.000 claims 3
- 101000854520 Homo sapiens Fractalkine Proteins 0.000 claims 3
- 101001068133 Homo sapiens Hepatitis A virus cellular receptor 2 Proteins 0.000 claims 3
- 101000878611 Homo sapiens High affinity immunoglobulin epsilon receptor subunit alpha Proteins 0.000 claims 3
- 101001037256 Homo sapiens Indoleamine 2,3-dioxygenase 1 Proteins 0.000 claims 3
- 101001034652 Homo sapiens Insulin-like growth factor 1 receptor Proteins 0.000 claims 3
- 101001015006 Homo sapiens Integrin beta-4 Proteins 0.000 claims 3
- 101001076418 Homo sapiens Interleukin-1 receptor type 1 Proteins 0.000 claims 3
- 101000852968 Homo sapiens Interleukin-1 receptor-like 1 Proteins 0.000 claims 3
- 101000998146 Homo sapiens Interleukin-17A Proteins 0.000 claims 3
- 101001010626 Homo sapiens Interleukin-22 Proteins 0.000 claims 3
- 101000853002 Homo sapiens Interleukin-25 Proteins 0.000 claims 3
- 101000960936 Homo sapiens Interleukin-5 receptor subunit alpha Proteins 0.000 claims 3
- 101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 claims 3
- 101001137987 Homo sapiens Lymphocyte activation gene 3 protein Proteins 0.000 claims 3
- 101000628535 Homo sapiens Metalloreductase STEAP2 Proteins 0.000 claims 3
- 101001128431 Homo sapiens Myeloid-derived growth factor Proteins 0.000 claims 3
- 101100460850 Homo sapiens NCR3LG1 gene Proteins 0.000 claims 3
- 101001109501 Homo sapiens NKG2-D type II integral membrane protein Proteins 0.000 claims 3
- 101000633520 Homo sapiens Natural cytotoxicity triggering receptor 3 ligand 1 Proteins 0.000 claims 3
- 101100407307 Homo sapiens PDCD1LG2 gene Proteins 0.000 claims 3
- 101000611936 Homo sapiens Programmed cell death protein 1 Proteins 0.000 claims 3
- 101000610551 Homo sapiens Prominin-1 Proteins 0.000 claims 3
- 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 claims 3
- 101000617130 Homo sapiens Stromal cell-derived factor 1 Proteins 0.000 claims 3
- 101000585365 Homo sapiens Sulfotransferase 2A1 Proteins 0.000 claims 3
- 101000831007 Homo sapiens T-cell immunoreceptor with Ig and ITIM domains Proteins 0.000 claims 3
- 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 claims 3
- 101000845170 Homo sapiens Thymic stromal lymphopoietin Proteins 0.000 claims 3
- 101000831567 Homo sapiens Toll-like receptor 2 Proteins 0.000 claims 3
- 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 claims 3
- 101000669460 Homo sapiens Toll-like receptor 5 Proteins 0.000 claims 3
- 101000795107 Homo sapiens Triggering receptor expressed on myeloid cells 1 Proteins 0.000 claims 3
- 101000638251 Homo sapiens Tumor necrosis factor ligand superfamily member 9 Proteins 0.000 claims 3
- 101000795167 Homo sapiens Tumor necrosis factor receptor superfamily member 13B Proteins 0.000 claims 3
- 101000795169 Homo sapiens Tumor necrosis factor receptor superfamily member 13C Proteins 0.000 claims 3
- 101000801234 Homo sapiens Tumor necrosis factor receptor superfamily member 18 Proteins 0.000 claims 3
- 101000864342 Homo sapiens Tyrosine-protein kinase BTK Proteins 0.000 claims 3
- 101001050476 Homo sapiens Tyrosine-protein kinase ITK/TSK Proteins 0.000 claims 3
- 101000955999 Homo sapiens V-set domain-containing T-cell activation inhibitor 1 Proteins 0.000 claims 3
- 102000026633 IL6 Human genes 0.000 claims 3
- 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 claims 3
- 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 claims 3
- 102100040061 Indoleamine 2,3-dioxygenase 1 Human genes 0.000 claims 3
- 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 claims 3
- 102100033000 Integrin beta-4 Human genes 0.000 claims 3
- 102100026016 Interleukin-1 receptor type 1 Human genes 0.000 claims 3
- 102000003814 Interleukin-10 Human genes 0.000 claims 3
- 108090000174 Interleukin-10 Proteins 0.000 claims 3
- 108010065805 Interleukin-12 Proteins 0.000 claims 3
- 102000013462 Interleukin-12 Human genes 0.000 claims 3
- 102000003812 Interleukin-15 Human genes 0.000 claims 3
- 108090000172 Interleukin-15 Proteins 0.000 claims 3
- 102100033461 Interleukin-17A Human genes 0.000 claims 3
- 102000003810 Interleukin-18 Human genes 0.000 claims 3
- 108090000171 Interleukin-18 Proteins 0.000 claims 3
- 102000000588 Interleukin-2 Human genes 0.000 claims 3
- 108010002350 Interleukin-2 Proteins 0.000 claims 3
- 102100026879 Interleukin-2 receptor subunit beta Human genes 0.000 claims 3
- 102100030703 Interleukin-22 Human genes 0.000 claims 3
- 108010065637 Interleukin-23 Proteins 0.000 claims 3
- 102000013264 Interleukin-23 Human genes 0.000 claims 3
- 102100036680 Interleukin-25 Human genes 0.000 claims 3
- 108010066979 Interleukin-27 Proteins 0.000 claims 3
- 102100036678 Interleukin-27 subunit alpha Human genes 0.000 claims 3
- 108010067003 Interleukin-33 Proteins 0.000 claims 3
- 102000017761 Interleukin-33 Human genes 0.000 claims 3
- 102000000743 Interleukin-5 Human genes 0.000 claims 3
- 108010002616 Interleukin-5 Proteins 0.000 claims 3
- 102100039881 Interleukin-5 receptor subunit alpha Human genes 0.000 claims 3
- 108090001005 Interleukin-6 Proteins 0.000 claims 3
- 102000000704 Interleukin-7 Human genes 0.000 claims 3
- 108010002586 Interleukin-7 Proteins 0.000 claims 3
- 102000002698 KIR Receptors Human genes 0.000 claims 3
- 108010043610 KIR Receptors Proteins 0.000 claims 3
- 102000017578 LAG3 Human genes 0.000 claims 3
- 102000016267 Leptin Human genes 0.000 claims 3
- 108010092277 Leptin Proteins 0.000 claims 3
- 102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 claims 3
- 102000043131 MHC class II family Human genes 0.000 claims 3
- 108091054438 MHC class II family Proteins 0.000 claims 3
- 101001043810 Macaca fascicularis Interleukin-7 receptor subunit alpha Proteins 0.000 claims 3
- 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 claims 3
- 102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 claims 3
- 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 claims 3
- 102100026711 Metalloreductase STEAP2 Human genes 0.000 claims 3
- 101000597780 Mus musculus Tumor necrosis factor ligand superfamily member 18 Proteins 0.000 claims 3
- 102100022680 NKG2-D type II integral membrane protein Human genes 0.000 claims 3
- 108010042215 OX40 Ligand Proteins 0.000 claims 3
- 102100040678 Programmed cell death protein 1 Human genes 0.000 claims 3
- 102100040120 Prominin-1 Human genes 0.000 claims 3
- 108050000258 Prostaglandin D receptors Proteins 0.000 claims 3
- 102100024218 Prostaglandin D2 receptor 2 Human genes 0.000 claims 3
- 101001037255 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Indoleamine 2,3-dioxygenase Proteins 0.000 claims 3
- 102100038081 Signal transducer CD24 Human genes 0.000 claims 3
- 102100021669 Stromal cell-derived factor 1 Human genes 0.000 claims 3
- 102100029867 Sulfotransferase 2A1 Human genes 0.000 claims 3
- 102000000551 Syk Kinase Human genes 0.000 claims 3
- 108010016672 Syk Kinase Proteins 0.000 claims 3
- 102100024834 T-cell immunoreceptor with Ig and ITIM domains Human genes 0.000 claims 3
- 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 claims 3
- 102100031294 Thymic stromal lymphopoietin Human genes 0.000 claims 3
- 108010060818 Toll-Like Receptor 9 Proteins 0.000 claims 3
- 102000002689 Toll-like receptor Human genes 0.000 claims 3
- 108020000411 Toll-like receptor Proteins 0.000 claims 3
- 102100024333 Toll-like receptor 2 Human genes 0.000 claims 3
- 102100039360 Toll-like receptor 4 Human genes 0.000 claims 3
- 102100039357 Toll-like receptor 5 Human genes 0.000 claims 3
- 102100033117 Toll-like receptor 9 Human genes 0.000 claims 3
- 102100029681 Triggering receptor expressed on myeloid cells 1 Human genes 0.000 claims 3
- 102100040653 Tryptophan 2,3-dioxygenase Human genes 0.000 claims 3
- 101710136122 Tryptophan 2,3-dioxygenase Proteins 0.000 claims 3
- 102100036922 Tumor necrosis factor ligand superfamily member 13B Human genes 0.000 claims 3
- 101710181056 Tumor necrosis factor ligand superfamily member 13B Proteins 0.000 claims 3
- 102100035283 Tumor necrosis factor ligand superfamily member 18 Human genes 0.000 claims 3
- 102100026890 Tumor necrosis factor ligand superfamily member 4 Human genes 0.000 claims 3
- 102100032101 Tumor necrosis factor ligand superfamily member 9 Human genes 0.000 claims 3
- 102100029675 Tumor necrosis factor receptor superfamily member 13B Human genes 0.000 claims 3
- 102100029690 Tumor necrosis factor receptor superfamily member 13C Human genes 0.000 claims 3
- 102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 claims 3
- 102100033728 Tumor necrosis factor receptor superfamily member 18 Human genes 0.000 claims 3
- 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 claims 3
- 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 claims 3
- 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 claims 3
- 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 claims 3
- 102100029823 Tyrosine-protein kinase BTK Human genes 0.000 claims 3
- 102100023345 Tyrosine-protein kinase ITK/TSK Human genes 0.000 claims 3
- 102100038929 V-set domain-containing T-cell activation inhibitor 1 Human genes 0.000 claims 3
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 claims 3
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 claims 3
- 201000007111 hereditary spastic paraplegia 64 Diseases 0.000 claims 3
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 claims 3
- 229940039781 leptin Drugs 0.000 claims 3
- 201000001278 lymphoproliferative syndrome 2 Diseases 0.000 claims 3
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 claims 3
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 150000007523 nucleic acids Chemical class 0.000 claims 3
- 108020003175 receptors Proteins 0.000 claims 3
- 102000005962 receptors Human genes 0.000 claims 3
- 235000011178 triphosphate Nutrition 0.000 claims 3
- 239000001226 triphosphate Substances 0.000 claims 3
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 claims 3
- 101100166600 Homo sapiens CD28 gene Proteins 0.000 claims 2
- 101001042104 Homo sapiens Inducible T-cell costimulator Proteins 0.000 claims 2
- 101001076386 Homo sapiens Interleukin-1 family member 10 Proteins 0.000 claims 2
- 101001055219 Homo sapiens Interleukin-9 receptor Proteins 0.000 claims 2
- 108091058560 IL8 Proteins 0.000 claims 2
- 102100021317 Inducible T-cell costimulator Human genes 0.000 claims 2
- 102100026015 Interleukin-1 family member 10 Human genes 0.000 claims 2
- 102100026244 Interleukin-9 receptor Human genes 0.000 claims 2
- 102100024584 Tumor necrosis factor ligand superfamily member 12 Human genes 0.000 claims 2
- 101710097155 Tumor necrosis factor ligand superfamily member 12 Proteins 0.000 claims 2
- 239000013604 expression vector Substances 0.000 claims 2
- IJJVMEJXYNJXOJ-UHFFFAOYSA-N fluquinconazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1N1C(=O)C2=CC(F)=CC=C2N=C1N1C=NC=N1 IJJVMEJXYNJXOJ-UHFFFAOYSA-N 0.000 claims 2
- 208000027866 inflammatory disease Diseases 0.000 claims 2
- 108010080422 CD39 antigen Proteins 0.000 claims 1
- 102000004127 Cytokines Human genes 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- 241000238631 Hexapoda Species 0.000 claims 1
- 101001033249 Homo sapiens Interleukin-1 beta Proteins 0.000 claims 1
- 102100039065 Interleukin-1 beta Human genes 0.000 claims 1
- 102000018697 Membrane Proteins Human genes 0.000 claims 1
- 108010052285 Membrane Proteins Proteins 0.000 claims 1
- 102100025237 T-cell surface antigen CD2 Human genes 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 229940127089 cytotoxic agent Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662322036P | 2016-04-13 | 2016-04-13 | |
| US62/322,036 | 2016-04-13 | ||
| US201662331191P | 2016-05-03 | 2016-05-03 | |
| US62/331,191 | 2016-05-03 | ||
| US201662412187P | 2016-10-24 | 2016-10-24 | |
| US62/412,187 | 2016-10-24 | ||
| EP17305298.6 | 2017-03-17 | ||
| EP17305298 | 2017-03-17 | ||
| PCT/US2017/027488 WO2017180913A2 (en) | 2016-04-13 | 2017-04-13 | Trispecific and/or trivalent binding proteins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019522459A JP2019522459A (ja) | 2019-08-15 |
| JP2019522459A5 true JP2019522459A5 (cg-RX-API-DMAC7.html) | 2020-05-07 |
| JP7195929B2 JP7195929B2 (ja) | 2022-12-26 |
Family
ID=58464471
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018554100A Active JP7195929B2 (ja) | 2016-04-13 | 2017-04-13 | 三重特異性および/または三価結合タンパク質 |
Country Status (23)
Families Citing this family (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI622597B (zh) * | 2011-03-28 | 2018-05-01 | 賽諾菲公司 | 具有交叉結合區定向之雙重可變區類抗體結合蛋白 |
| AR103488A1 (es) * | 2015-01-23 | 2017-05-10 | Sanofi Sa | Anticuerpos anti-cd3, anticuerpos anti-cd123 y anticuerpos biespecíficos que se unen específicamente a cd3 y/o cd123 |
| AR106188A1 (es) | 2015-10-01 | 2017-12-20 | Hoffmann La Roche | Anticuerpos anti-cd19 humano humanizados y métodos de utilización |
| ES2894304T3 (es) | 2015-10-25 | 2022-02-14 | Sanofi Sa | Proteínas de unión triespecíficas y/o trivalentes para la prevención o tratamiento de infección por VIH |
| MY192090A (en) | 2016-04-13 | 2022-07-26 | Sanofi Sa | Trispecific and/or trivalent binding proteins |
| EP3443006B1 (en) * | 2016-04-13 | 2023-08-02 | Sanofi | Trispecific and/or trivalent binding proteins |
| EP3448874A4 (en) | 2016-04-29 | 2020-04-22 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| KR102654105B1 (ko) | 2017-02-17 | 2024-04-04 | 사노피 | 디스트로글리칸 및 라미닌-2에 대한 특이성을 갖는 다중특이적 결합 분자 |
| CN110997714B (zh) | 2017-02-17 | 2024-05-03 | 赛诺菲 | 对肌营养不良蛋白聚糖和层粘连蛋白-2具有特异性的多特异性结合分子 |
| WO2018151841A1 (en) | 2017-02-17 | 2018-08-23 | Sanofi | Multispecific binding molecules having specificity to dystroglycan and laminin-2 |
| BR112019017628A2 (pt) | 2017-02-24 | 2020-07-07 | Macrogenics, Inc. | molécula de ligação a cd137 x ta, composições farmacêuticas, uso da molécula de ligação a cd137 x ta, molécula de ligação a cd137, uso da molécula de ligação a cd137, molécula de ligação a her2/neu, uso da molécula de ligação a her2/neu, e uso de uma composição |
| UY37758A (es) | 2017-06-12 | 2019-01-31 | Novartis Ag | Método de fabricación de anticuerpos biespecíficos, anticuerpos biespecíficos y uso terapéutico de dichos anticuerpos |
| CN111788225B (zh) | 2017-10-10 | 2025-02-18 | 赛诺菲 | 抗cd38抗体及与抗cd3和抗cd28抗体的组合 |
| PE20210844A1 (es) * | 2017-11-01 | 2021-05-10 | Hoffmann La Roche | Contorsbodies 2 + biespecificos |
| EP3713959A1 (en) * | 2017-11-21 | 2020-09-30 | Innate Pharma | Multispecific antigen binding proteins |
| CN109957026A (zh) * | 2017-12-22 | 2019-07-02 | 成都恩沐生物科技有限公司 | 共价多特异性抗体 |
| CN111448217A (zh) | 2017-12-22 | 2020-07-24 | 阿根思公司 | 双特异性抗原结合构建体 |
| US12247060B2 (en) | 2018-01-09 | 2025-03-11 | Marengo Therapeutics, Inc. | Calreticulin binding constructs and engineered T cells for the treatment of diseases |
| IL275536B2 (en) | 2018-01-12 | 2025-06-01 | Genzyme Corp | Methods for quantification of polypeptides |
| CN111787949A (zh) | 2018-02-15 | 2020-10-16 | 宏观基因有限公司 | 变体cd3-结合结构域及其在用于治疗疾病的组合疗法中的用途 |
| GB201802487D0 (en) | 2018-02-15 | 2018-04-04 | Argenx Bvba | Cytokine combination therapy |
| WO2019166650A1 (en) * | 2018-03-02 | 2019-09-06 | Cdr-Life Ag | Trispecific antigen binding proteins |
| MX2020009326A (es) * | 2018-03-08 | 2020-10-08 | Phanes Therapeutics Inc | Anticuerpos anti-claudina 18.2 y usos de los mismos. |
| EP3765517A1 (en) | 2018-03-14 | 2021-01-20 | Elstar Therapeutics, Inc. | Multifunctional molecules that bind to calreticulin and uses thereof |
| EP3765516A2 (en) * | 2018-03-14 | 2021-01-20 | Elstar Therapeutics, Inc. | Multifunctional molecules and uses thereof |
| CN120463807A (zh) | 2018-03-22 | 2025-08-12 | 表面肿瘤学有限责任公司 | 抗il-27抗体及其用途 |
| EP3773621A4 (en) * | 2018-03-27 | 2022-03-23 | Systimmune, Inc. | GUIDANCE AND NAVIGATION CONTROL PROTEINS AND METHODS FOR THEIR MANUFACTURE AND USE |
| US10654944B2 (en) * | 2018-04-10 | 2020-05-19 | Y-Biologics Inc. | Cell engaging binding molecules |
| CN112384243A (zh) * | 2018-04-17 | 2021-02-19 | 英温拉公司 | 三价三特异性抗体构建体 |
| CN112912103B (zh) * | 2018-05-21 | 2025-08-29 | 广州邦定生物技术有限公司 | 多价蛋白质复合物 |
| WO2020010250A2 (en) | 2018-07-03 | 2020-01-09 | Elstar Therapeutics, Inc. | Anti-tcr antibody molecules and uses thereof |
| CA3108427A1 (en) * | 2018-08-08 | 2020-02-13 | Dragonfly Therapeutics, Inc. | Multi-specific binding proteins that bind bcma, nkg2d and cd16, and methods of use |
| MX2021002165A (es) | 2018-08-23 | 2021-07-16 | Regeneron Pharma | Anticuerpos anti-fc épsilon-r1 alfa (fcer1a), moléculas de unión a antígeno biespecíficas que se unen a fcer1a y cd3 y usos de éstos. |
| TWI856979B (zh) * | 2018-10-09 | 2024-10-01 | 法商賽諾菲公司 | 三特異性抗cd38、抗cd28和抗cd3結合蛋白和用於治療病毒感染的使用方法 |
| CN111153988B (zh) * | 2018-11-08 | 2022-11-04 | 中国科学院上海巴斯德研究所 | 广谱抗肠道病毒d68型的中和性单克隆抗体 |
| JP7734075B2 (ja) | 2018-12-24 | 2025-09-04 | サノフイ | 疑似fabベースの多重特異性結合タンパク質 |
| WO2020136566A1 (en) * | 2018-12-24 | 2020-07-02 | Sanofi | Multispecific binding proteins with mutant fab domains |
| EP3674316A1 (en) | 2018-12-24 | 2020-07-01 | Sanofi | Multispecific binding proteins with mutant fab domains |
| WO2020172259A1 (en) * | 2019-02-20 | 2020-08-27 | Research Institute At Nationwide Children's Hospital | Cancer-targeted, virus-encoded, regulatable t (catvert) or nk cell (catvern) linkers |
| AU2020226893B2 (en) | 2019-02-21 | 2025-02-27 | Marengo Therapeutics, Inc. | Multifunctional molecules that bind to T cell related cancer cells and uses thereof |
| JP7579795B2 (ja) | 2019-02-21 | 2024-11-08 | マレンゴ・セラピューティクス,インコーポレーテッド | NKp30に結合する抗体分子およびその使用 |
| US11613576B2 (en) | 2019-04-09 | 2023-03-28 | Sanofi | Trispecific binding proteins, methods, and uses thereof |
| TW202104274A (zh) | 2019-04-09 | 2021-02-01 | 法商賽諾菲公司 | 用於治療hiv感染之三特異性及/或三價結合蛋白 |
| JP7664175B2 (ja) * | 2019-04-09 | 2025-04-17 | サノフイ | 三重特異性結合性タンパク質、方法、およびその使用 |
| CN116987197A (zh) * | 2019-06-20 | 2023-11-03 | 成都恩沐生物科技有限公司 | 共价多特异性抗体 |
| US12435131B2 (en) | 2019-07-11 | 2025-10-07 | Tavotek Biotherapeutics (Hong Kong) Limited | Agents that interfere with thymic stromal lymphopoietin (TSLP)-receptor signaling |
| CN113166273A (zh) * | 2019-07-25 | 2021-07-23 | 天境生物科技(上海)有限公司 | 具有il-7活性的双功能分子 |
| MX2022004881A (es) | 2019-10-25 | 2022-05-16 | Sanofi Sa | Metodos para analizar el emparejamiento incorrecto de cadenas en proteinas de union multiespecificas. |
| AU2020379735A1 (en) * | 2019-11-05 | 2022-05-26 | Regeneron Pharmaceuticals, Inc. | N-terminal SCFV multispecific binding molecules |
| WO2021138474A2 (en) | 2020-01-03 | 2021-07-08 | Marengo Therapeutics, Inc. | Anti-tcr antibody molecules and uses thereof |
| WO2021146413A1 (en) * | 2020-01-16 | 2021-07-22 | Caerus Therapeutics, Inc. | Humanized antibodies specific for myeloma and ovarian cancer cells |
| WO2021173844A1 (en) | 2020-02-26 | 2021-09-02 | Biograph 55, Inc. | C19 c38 bispecific antibodies |
| TW202146463A (zh) | 2020-03-05 | 2021-12-16 | 法商賽諾菲公司 | 蛋白酶加工的分子 |
| WO2021198204A1 (en) * | 2020-03-30 | 2021-10-07 | Sanofi | Split ch2 domains |
| CR20220627A (es) | 2020-06-23 | 2023-02-17 | Hoffmann La Roche | Moléculas agonistas de unión al antígeno cd28 que se derigen a her2 |
| EP4545569A3 (en) * | 2020-06-30 | 2025-10-08 | Harbour Biomed (Shanghai) Co., Ltd | Binding protein having h2l2 and hcab structures |
| WO2022036495A1 (en) | 2020-08-17 | 2022-02-24 | Utc Therapeutics Inc. | Lymphocytes-antigen presenting cells co-stimulators and uses thereof |
| CA3192465A1 (en) | 2020-09-18 | 2022-03-24 | Laure Bouchez | Cd47-cd38 bispecific antibodies |
| JP7905328B2 (ja) * | 2020-09-18 | 2026-08-14 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | Cd38及び/又はcd28を結合する抗原結合分子及びその使用 |
| CA3201637A1 (en) | 2020-11-18 | 2022-05-27 | Novartis Ag | Bispecific antibodies for use in treatment of nlrc4-gof inflammasomapathy |
| TW202306584A (zh) | 2021-05-27 | 2023-02-16 | 法商賽諾菲公司 | 具有對Fc受體之增強親和力及改良熱穩定性的Fc變體 |
| CN118317979A (zh) * | 2021-09-29 | 2024-07-09 | 摩德斯医疗股份有限公司 | 抗原结合多肽、抗原结合多肽复合物及其使用方法 |
| TW202330594A (zh) * | 2021-09-29 | 2023-08-01 | 美商莫德斯醫療公司 | 抗原結合多肽、抗原結合多肽複合物及其使用方法 |
| EP4408892A4 (en) * | 2021-09-29 | 2025-11-19 | Modex Therapeutics Inc | Antigen-binding polypeptides, antigen-binding polypeptide complexes, and their methods of use in HIV |
| US20250034273A1 (en) * | 2021-10-08 | 2025-01-30 | Arbele Limited | Composition of multispecific antibodies targeting cadherin-17-expressing tumors and method of making and using thereof |
| EP4480966A4 (en) * | 2022-02-16 | 2026-01-28 | Utc Therapeutics Shanghai Co Ltd | Humanized anti-CD28 antibody and bispecific antibody combining it with an anti-CD40 antibody |
| IL315262A (en) * | 2022-03-03 | 2024-10-01 | Pfizer | Multiple specific antibodies related to IL-4, IL-13 and/or TSLP and their uses |
| US12692314B2 (en) | 2022-05-06 | 2026-07-28 | IGI Therapeutics SA | CD3/BCMA/CD38 trispecific antibodies |
| WO2023227790A1 (en) | 2022-05-27 | 2023-11-30 | Sanofi | Natural killer (nk) cell engagers binding to nkp46 and bcma variants with fc-engineering |
| KR20250025381A (ko) | 2022-06-17 | 2025-02-21 | 아포지 바이오로직스, 인크. | 인터류킨 13에 결합하는 항체 및 사용 방법 |
| WO2023246911A1 (zh) * | 2022-06-24 | 2023-12-28 | 北京可瑞生物科技有限公司 | 基于t细胞受体的双特异性多肽分子及其用途 |
| JP2025528087A (ja) * | 2022-08-05 | 2025-08-26 | チマゲン・バイオサイエンシズ,リミテッド | 二量体化可能な腫瘍抗原及び免疫刺激抗原を標的とする多重特異性抗体 |
| CN120418284A (zh) * | 2022-12-19 | 2025-08-01 | 和铂医药(上海)有限责任公司 | “κ/λ” Fab-Fab串联多特异性结合蛋白及其制备和应用 |
| TW202440636A (zh) | 2023-03-21 | 2024-10-16 | 美商傳記55有限公司 | Cd19/cd38多特異性抗體 |
| WO2025006794A1 (en) * | 2023-06-29 | 2025-01-02 | Promab Biotechnologies, Inc. | Her-2 -cd3-epsilon bispecific antibodies |
| CN121586731A (zh) | 2023-07-31 | 2026-02-27 | 赛诺菲 | 抗cd38 t细胞接合器在治疗外周t细胞淋巴瘤中的方法和用途 |
| JP7855651B2 (ja) * | 2023-08-30 | 2026-05-08 | ファイザー・インク | 多重特異性抗体およびその使用 |
| WO2025238419A1 (en) | 2024-05-17 | 2025-11-20 | Sanofi | Methods of treating cancer using trispecific binding proteins targeting her2-expressing tumors |
| TW202619716A (zh) | 2024-07-23 | 2026-05-16 | 法商賽諾菲公司 | Cereblon連接酶調節劑與bcma nk細胞銜接子的組合療法 |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1338518C (en) | 1987-09-23 | 1996-08-13 | Joyce M. Zarling | Antibody heteroconjugates for the killing of hiv-infected cells |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| CA2323757C (en) | 1998-04-02 | 2011-08-02 | Genentech, Inc. | Antibody variants and fragments thereof |
| EP1361892A4 (en) * | 2001-01-17 | 2004-10-13 | Trubion Pharmaceuticals Inc | BINDING DOMAIN FUSION PROTEIN Immunoglobulin |
| CN1294148C (zh) * | 2001-04-11 | 2007-01-10 | 中国科学院遗传与发育生物学研究所 | 环状单链三特异抗体 |
| US7700097B2 (en) | 2003-06-27 | 2010-04-20 | Biogen Idec Ma Inc. | Purification and preferential synthesis of binding molecules |
| US9200061B2 (en) | 2004-02-06 | 2015-12-01 | Morpho Sys AG | Generation and profiling of fully human HuCAL gold®-derived therapeutic antibodies specific for human CD3i |
| CN100376599C (zh) | 2004-04-01 | 2008-03-26 | 北京安波特基因工程技术有限公司 | 基因工程重组抗cea抗cd3抗cd28线性单链三特异抗体 |
| EP2050764A1 (en) | 2007-10-15 | 2009-04-22 | sanofi-aventis | Novel polyvalent bispecific antibody format and uses thereof |
| EP2297209A4 (en) | 2008-06-03 | 2012-08-01 | Abbott Lab | IMMUNOGLOBULINS WITH TWO VARIABLE DOMAINS AND USES THEREOF |
| US9175070B2 (en) | 2009-09-25 | 2015-11-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Neutralizing antibodies to HIV-1 and their use |
| EP2580243B1 (en) | 2010-06-09 | 2019-10-16 | Genmab A/S | Antibodies against human cd38 |
| JOP20210044A1 (ar) * | 2010-12-30 | 2017-06-16 | Takeda Pharmaceuticals Co | الأجسام المضادة لـ cd38 |
| TWI622597B (zh) | 2011-03-28 | 2018-05-01 | 賽諾菲公司 | 具有交叉結合區定向之雙重可變區類抗體結合蛋白 |
| WO2012154312A1 (en) | 2011-05-09 | 2012-11-15 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Neutralizing antibodies to hiv-1 and their use |
| JP6400470B2 (ja) | 2011-05-16 | 2018-10-03 | ジェネロン(シャンハイ)コーポレイション リミテッド | 多重特異性Fab融合タンパク質および使用法 |
| CN112225798B (zh) | 2011-05-17 | 2023-07-18 | 洛克菲勒大学 | 人类免疫缺陷病毒中和抗体及其使用方法 |
| CN104080805B (zh) | 2011-11-07 | 2017-02-22 | 美国政府健康及人类服务部 | gp41中和性抗体及其用途 |
| CN104271597B (zh) | 2011-12-08 | 2018-05-25 | 美国政府(由卫生和人类服务部的部长所代表) | Hiv-1的中和抗体及其用途 |
| WO2013163427A1 (en) | 2012-04-25 | 2013-10-31 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Antibodies to treat hiv-1 infection |
| JOP20200236A1 (ar) | 2012-09-21 | 2017-06-16 | Regeneron Pharma | الأجسام المضادة لمضاد cd3 وجزيئات ربط الأنتيجين ثنائية التحديد التي تربط cd3 وcd20 واستخداماتها |
| US20150239991A1 (en) * | 2012-09-25 | 2015-08-27 | Glenmark Pharmaceuticals S.A. | Purification of hetero-dimeric immunoglobulins |
| US20140213772A1 (en) * | 2012-12-28 | 2014-07-31 | Abbvie, Inc. | Cross-over dual variable domain immunoglobulin constructs |
| US10487155B2 (en) | 2013-01-14 | 2019-11-26 | Xencor, Inc. | Heterodimeric proteins |
| EP2948475A2 (en) * | 2013-01-23 | 2015-12-02 | AbbVie Inc. | Methods and compositions for modulating an immune response |
| CN110437337B (zh) * | 2013-02-26 | 2024-07-30 | 罗切格利卡特公司 | 双特异性t细胞活化性抗原结合分子 |
| US20140302037A1 (en) * | 2013-03-15 | 2014-10-09 | Amgen Inc. | BISPECIFIC-Fc MOLECULES |
| CA2904407A1 (en) * | 2013-03-15 | 2014-09-18 | Abbvie Inc. | Dual specific binding proteins directed against tnf.alpha. |
| AP2016009222A0 (en) | 2013-11-04 | 2016-05-31 | Glenmark Pharmaceuticals Sa | Production of t cell retargeting hetero-dimeric immunoglobulins |
| PL3122781T3 (pl) * | 2014-03-28 | 2020-06-15 | Xencor, Inc. | Dwuswoiste przeciwciała, które wiążą się z CD38 i CD3 |
| BR112017004270B1 (pt) | 2014-09-04 | 2023-03-07 | Stemcell Technologies Inc | Método de ativação de células t ou células nk |
| AR103488A1 (es) | 2015-01-23 | 2017-05-10 | Sanofi Sa | Anticuerpos anti-cd3, anticuerpos anti-cd123 y anticuerpos biespecíficos que se unen específicamente a cd3 y/o cd123 |
| WO2016196740A1 (en) | 2015-06-02 | 2016-12-08 | The Rockefeller University | Tri-specific antibodies for hiv therapy |
| JP6991131B2 (ja) | 2015-09-22 | 2022-02-03 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | Hiv感染症を処置するためにt細胞を再度方向付ける方法 |
| ES2894304T3 (es) * | 2015-10-25 | 2022-02-14 | Sanofi Sa | Proteínas de unión triespecíficas y/o trivalentes para la prevención o tratamiento de infección por VIH |
| CN105837688B (zh) | 2015-11-20 | 2019-02-26 | 北京大学深圳研究生院 | 单域抗体及其编码基因,免疫毒素及其编码基因、制备方法、表达载体、应用,及宿主细胞 |
| JP6732915B2 (ja) | 2015-12-15 | 2020-07-29 | ギリアード サイエンシーズ, インコーポレイテッド | ヒト免疫不全ウイルス中和抗体 |
| EP3443006B1 (en) | 2016-04-13 | 2023-08-02 | Sanofi | Trispecific and/or trivalent binding proteins |
| EP3575319A4 (en) | 2016-12-30 | 2021-03-10 | Shanghai Sinobio Biotech Co., Ltd. | BIFUNCTIONAL MOLECULE AND USE OF IT |
| WO2018151841A1 (en) | 2017-02-17 | 2018-08-23 | Sanofi | Multispecific binding molecules having specificity to dystroglycan and laminin-2 |
| KR102654105B1 (ko) | 2017-02-17 | 2024-04-04 | 사노피 | 디스트로글리칸 및 라미닌-2에 대한 특이성을 갖는 다중특이적 결합 분자 |
| CN111788225B (zh) | 2017-10-10 | 2025-02-18 | 赛诺菲 | 抗cd38抗体及与抗cd3和抗cd28抗体的组合 |
| TWI856979B (zh) | 2018-10-09 | 2024-10-01 | 法商賽諾菲公司 | 三特異性抗cd38、抗cd28和抗cd3結合蛋白和用於治療病毒感染的使用方法 |
| US11613576B2 (en) | 2019-04-09 | 2023-03-28 | Sanofi | Trispecific binding proteins, methods, and uses thereof |
-
2017
- 2017-04-13 EP EP17732263.3A patent/EP3443006B1/en active Active
- 2017-04-13 WO PCT/US2017/027488 patent/WO2017180913A2/en not_active Ceased
- 2017-04-13 TW TW106112360A patent/TWI788286B/zh active
- 2017-04-13 US US15/487,243 patent/US10882922B2/en active Active
- 2017-04-13 KR KR1020187032530A patent/KR20180134378A/ko not_active Ceased
- 2017-04-13 BR BR112018070998-0A patent/BR112018070998A2/pt not_active Application Discontinuation
- 2017-04-13 PE PE2018001987A patent/PE20190128A1/es unknown
- 2017-04-13 IL IL262241A patent/IL262241B2/en unknown
- 2017-04-13 MA MA44670A patent/MA44670B1/fr unknown
- 2017-04-13 SG SG11201808911SA patent/SG11201808911SA/en unknown
- 2017-04-13 EA EA201892312A patent/EA201892312A1/ru unknown
- 2017-04-13 CN CN201780036515.9A patent/CN109476732B/zh active Active
- 2017-04-13 JP JP2018554100A patent/JP7195929B2/ja active Active
- 2017-04-13 PT PT177322633T patent/PT3443006T/pt unknown
- 2017-04-13 CR CR20180539A patent/CR20180539A/es unknown
- 2017-04-13 AU AU2017248671A patent/AU2017248671B2/en active Active
- 2017-04-13 MX MX2018012566A patent/MX2018012566A/es unknown
- 2017-04-13 CA CA3020633A patent/CA3020633A1/en active Pending
- 2017-04-18 UY UY0001037206A patent/UY37206A/es not_active Application Discontinuation
-
2018
- 2018-10-10 CL CL2018002883A patent/CL2018002883A1/es unknown
- 2018-10-11 PH PH12018502182A patent/PH12018502182A1/en unknown
- 2018-10-12 DO DO2018000225A patent/DOP2018000225A/es unknown
- 2018-11-09 CO CONC2018/0012107A patent/CO2018012107A2/es unknown
-
2020
- 2020-11-16 US US17/099,439 patent/US11192960B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11192960B2 (en) | Trispecific and/or trivalent binding proteins | |
| US20120201746A1 (en) | Half immunoglobulin binding proteins and uses thereof | |
| IL261673A (en) | Protein-like binding proteins with a double variable region have a cross-linking region direction | |
| US20120195900A1 (en) | Tri-variable domain binding proteins and uses thereof | |
| US20090215992A1 (en) | Dual variable domain immunoglobulin and uses thereof | |
| US20110318349A1 (en) | Dual variable domain immunoglobulins and uses thereof | |
| WO2008024188A2 (en) | Dual variable domain immunoglobulin and uses thereof | |
| JP2025503480A5 (cg-RX-API-DMAC7.html) | ||
| US11932704B2 (en) | Trispecific and/or trivalent binding proteins | |
| RU2023128356A (ru) | Антитела к cd38 и комбинации с антителами к cd3 и сd28 | |
| RU2024102366A (ru) | Антитела к cd38 и комбинации с антителами к cd3 и сd28 | |
| RU2020115450A (ru) | Антитела к cd38 и комбинации с антителами к cd3 и cd28 | |
| TH1801006399A (th) | โปรตีนการจับชนิดไตรสเปซิฟิกและ/หรือไตรวาเลนต์ | |
| HK40101445A (en) | Trispecific and/or trivalent binding proteins | |
| HK1260494A1 (en) | Trispecific and/or trivalent binding proteins | |
| HK1260494B (en) | Trispecific and/or trivalent binding proteins | |
| BR122024005246A2 (pt) | Método de purificação de uma proteína de ligação produzida por uma célula hospedeira |